XML 38 R28.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2026
Stockholders' Equity  
Schedule of shareholder's equity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

​

​

  ​ ​ ​

Accumulated

  ​ ​ ​

​

​

  ​ ​ ​

​

​

​

​

Common

​

Common

​

Additional

​

Other

​

​

​

​

Total

​

​

Stock

​

Stock Par

​

Paid-In

​

Comprehensive

​

Accumulated

​

Stockholders’

​

  ​ ​ ​

Shares

  ​ ​ ​

Value

  ​ ​ ​

Capital

  ​ ​ ​

Income

  ​ ​ ​

Deficit

  ​ ​ ​

Equity

​

​

(In thousands, except share amounts)

Consolidated balance at December 31, 2025

 

66,549,442

​

$

67

​

$

2,337,453

​

$

3,626

​

$

(1,813,981)

​

$

527,165

Shares issued under stock option and employee stock purchase plans

 

19,529

​

​

—

​

​

327

​

​

—

​

​

—

​

​

327

Stock-based compensation

 

—

​

​

—

​

​

8,523

​

​

—

​

​

—

​

​

8,523

Unrealized loss on marketable securities

 

—

​

​

—

​

​

—

​

​

(1,104)

​

​

—

​

​

(1,104)

Net loss

 

—

​

​

—

​

​

—

​

​

—

​

​

(78,685)

​

​

(78,685)

Consolidated balance at March 31, 2026

 

66,568,971

​

$

67

​

$

2,346,303

​

$

2,522

​

$

(1,892,666)

​

$

456,226

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

​

​

  ​ ​ ​

Accumulated

  ​ ​ ​

​

​

  ​ ​ ​

​

​

​

​

Common

​

Common

​

Additional

​

Other

​

​

​

​

Total

​

​

Stock

​

Stock Par

​

Paid-In

​

Comprehensive

​

Accumulated 

​

Stockholders’

​

​

Shares

​

Value

​

Capital

​

Income

​

Deficit

​

Equity

​

​

(In thousands, except share amounts)

Consolidated balance at December 31, 2024

 

66,374,549

​

$

66

​

$

2,298,849

​

$

3,314

​

$

(1,555,224)

​

$

747,005

Shares issued under stock option and employee stock purchase plans

 

9,642

​

​

—

​

​

202

​

​

—

​

​

—

​

​

202

Stock-based compensation

 

—

​

​

—

​

​

9,316

​

​

—

​

​

—

​

​

9,316

Unrealized gain on marketable securities

 

—

​

​

—

​

​

—

​

​

254

​

​

—

​

​

254

Net loss

 

—

​

​

—

​

​

—

​

​

—

​

​

(53,796)

​

​

(53,796)

Consolidated balance at March 31, 2025

 

66,384,191

​

$

66

​

$

2,308,367

​

$

3,568

​

$

(1,609,020)

​

$

702,981

​